Thelansis

 Acute lymphoblastic leukemia (ALL) is a cancerous overgrowth of early-stage lymphoid cells that can infiltrate the bone marrow, blood, and other tissue sites. Although most ALL cases occur in individuals without prior health issues, there have been cases where inherited genetic susceptibility and environmental factors played a role. In the pediatric population, specific genetic syndromes have been linked to an increased risk of developing ALL, and common allelic variations have been associated with a greater likelihood of the disease, often with cumulative effects. ALL can be classified into two types: B-cell and T-cell, distinguished by chromosomal abnormalities and genetic mutations that impact the development and multiplication of lymphoid precursor cells. These abnormalities influence how patients respond to treatment and serve as significant indicators of prognosis. It's worth noting that most ALL cases are diagnosed in children, with most ALL-related deaths occurring in adul